T-ZELL-REZEPTOREN

European patent · EP3578188 · In force

Register entry

Publication number
EP3578188
Application number
EP19172518
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 18, 2014
Published
Dec 11, 2019
Granted
Feb 23, 2022
Protection ends at the latest
Jul 17, 2034
Next annual fee due
Jul 31, 2027
IPC classes
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
A61P 37/04 (2006.01)
C07K 14/725 (2006.01)
A61K 38/00 (2006.01)
C12N 5/0783 (2010.01)
A61K 39/00 (2006.01)
Priority
GB 201313377 26.07.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  6. Aug 8, 2022

    Change

    Published in Swissreg on 08.08.2022

  7. Feb 23, 2022

    Granted

    Published in Swissreg on 23.02.2022

Parties

Holder

Adaptimmune Limited

60 Jubilee Avenue Milton Park, Abingdon, Oxfordshire OX14 4RX, GB

Inventor

MOLLOY, Peter

Abingdon, Oxfordshire OX14 4RY, GB

PUMPHREY, Nicholas Jonathan

Abingdon, Oxfordshire OX14 4RY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.